Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

Another Marijuana Myth Goes Up In Smoke

Paul Armentano

LewRockwell.com

Friday 09 Jun 2006

---
Epidemiological data presented last May at the International Conference
of the American Thoracic Society
(http://www.foxnews.com/story/0,2933,196678,00.html) concluding that
smoking marijuana, even long-term, is not positively associated with
increased incidence of lung-cancer, is just the latest in a long line of
government claims regarding the alleged dangers of pot to go – pardon
the pun – up in smoke.

Investigators from the David Geffen School of Medicine at the University
of California assessed the possible association between cannabis use and
the risk of lung cancer in middle-aged adults (ages 18–59) living in Los
Angeles. Researchers conducted interviews with 611 subjects with lung
cancer and 1,040 controls matched for age, gender, and neighborhood.
Data was collected on lifetime marijuana use, as well as subjects' use
of alcohol, tobacco and other drugs, diet, occupation, and family
history of cancer. Investigators used a logistical regression model to
estimate the effect of cannabis smoking on lung cancer risk, adjusting
for age, gender, ethnicity, education, cumulative tobacco smoking, and
alcohol use.

"We did not observe a positive association of marijuana use – even heavy
long-term use – with lung cancer, controlling for tobacco smoking and
other potential cofounders," investigators concluded. Moreover, their
data further revealed that one subset of moderate lifetime users
actually had an inverse association between cannabis use and lung
cancer. Much less surprising, the NIH-funded study – the largest of its
type ever conducted – did find a 20-fold increased risk in heavy tobacco
smokers.

Officials from the White House’s Drug Czar’s office had "no comment" on
the UCLA findings.

While the investigators’ failure to demonstrate a positive association
between cannabis use and cancer may seem surprising to some, the bottom
line is that scientists overseas have been studying pot’s potential
anti-cancer properties for nearly a decade. Most recently, investigators
at Italy's Instuto di Chemica Biomolecolare reported in the May issue of
the Journal of Pharmacology and Experimental Therapeutics
(http://jpet.aspetjournals.org/cgi/reprint/jpet.106.105247v1) that
compounds in marijuana inhibit cancer cell growth in animals and in
culture on a wide range of tumor cell lines, including human breast
carcinoma cells, human prostate carcinoma cells, and human colectoral
carcinoma cells.

Previous studies by European researchers have shown that cannabis’
constituents can reduce the size and halt the spread of glioma (brain
tumor) cells in animals and humans in a dose dependent manner. Separate
preclinical studies (http://www.lewrockwell.com/orig5/armentano-p1.html)
have also shown marijuana to inhibit cancer cell growth and selectively
trigger malignant cell death in skin cancer cells, leukemic cells, and
lung cancer cells, among other cancerous cell lines.

But none of these findings should come as a surprise to the US
government, which ironically, sponsored the first experiment ever
documenting pot's anti-cancer effects in 1974 at the Medical College of
Virginia (http://www.lewrockwell.com/armentano-p/v) . The results of
that study, reported in an Aug. 18, 1974, Washington Post newspaper
feature, were that marijuana's primary psychoactive component "THC
slowed the growth of lung cancers, breast cancers and a virus-induced
leukemia in laboratory mice, and prolonged their lives by as much as 36
percent."

Shockingly, federal officials have steadfastly refused to fund any
follow up research on the subject in the following decades, and today
continue to oppose any use of cannabis – even for medical purposes in
states that have authorized its use. What’s the Fed’s rational for
maintaining such a foolish and misguided policy? Most likely, they have
"no comment."

Paul Armentano [send him mail paul@norml.org] is the senior policy
analyst for the NORML Foundation in Washington, DC.
http://www.lewrockwell.com/armentano-p/armentano-p11.htm

 

 

 

After you have finished reading this article you can click here to go back.




This page was created by the Cannabis Campaigners' Guide.
Feel free to link to this page!